BioSpectrum Asia
June 2025
Partnerships are a cornerstone of the biotech innovation process. COVID-19 acted as a catalyst, accelerating collaboration across the sector and prompting partnerships between established players for the first time. Since then, biotech alliances have become more diverse, frequent, and strategically important, especially in the Asia-Pacific (APAC) region. Let's explore the APAC's wave of regional biotech partnerships during the first five months of this calendar year i.e. from January to May 2025.
ARTICLES
APAC's Alliance-Driven Biotech Boom
Partnerships are a cornerstone of the biotech innovation process. COVID-19 acted as a catalyst,
accelerating collaboration across the sector and prompting partnerships between established
players for the first time. Since then, biotech alliances have become more diverse, frequent, and
strategically important, especially in the Asia-Pacific (APAC) region. Let's explore the APAC's wave of
regional biotech partnerships during the first five months of this calendar year i.e. from January to
May 2025.
Read more →
Upskilling and flexibility are key to staying relevant as hiring grows
With ongoing uncertainty, geopolitical tensions, and recession risks, the life sciences job market
remains volatile. The year 2024 saw continued layoffs, cautious investor sentiment, and growing
competition for fewer job openings. As biopharma companies restructure, hiring patterns are changing,
especially at mid and senior levels. What are the current trends, and which sectors are hiring the most?
Let's find out.
Read more →
MedTech Disruption 2025: Startups Powering the Next Healthcare Leap
As the MedTech industry strides into 2025 and beyond, innovations are transforming the way diagnosis,
treatment, and patient engagement are delivered. These advancements are centred around patient-centric care,
the convergence of digital technologies, preventive health care, and personalised therapy – all aimed at
improving outcomes and maximising patient satisfaction.
Read more →
Beyond the Algorithm: Why MedComms Still Need Human Pulse
In an industry, now shaped by artificial intelligence (AI)-driven efficiencies and machine-generated drafts,
it's natural to wonder: Is the medical communicator (MedComm) becoming obsolete? After all, algorithms can
analyse thousands of clinical studies in minutes, format citations instantly, and draft documents that read,
at first glance, like they were written by seasoned professionals.
Read more →
Addressing Women's Health with Portable Devices
The confluence of innovation, affordability, and accessibility creates a compelling market proposition for
healthcare providers, diagnostic chains, corporate wellness programmes, and public health systems alike in
cancer care with focus on women's cancer in Asia. By Gauri Navalkar Godse, Director and CEO, India,
UE LifeSciences shares her thoughts.
Read more →
Emerging GCC Hotspots in APAC: Spotlight on Singapore, Malaysia, and the Philippines
The Asia-Pacific (APAC) region is now a top choice for Life Sciences and Healthcare (LSHC) multinationals
to establish their Global Capability Centres (GCCs). India leads with over 100 GCCs, while countries like
Singapore, Malaysia, and the Philippines offer cost-effective advantages, says Dr Purav Gandhi, CEO and
Founder, Healthark Insights.
Read more →
